Two Sigma Advisers
AMRI

Two Sigma Advisers’s Albany Molecular Research Inc AMRI Stock Holding History

Two Sigma Advisers’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-43,700
Closed -$948K – 2452
2017
Q2 		$948K Sell
43,700
-35,400
-45% -$642K ﹤0.01% 1545
2017
Q1 		$1.11M Buy
+79,100
New +$1.3M ﹤0.01% 1531
2016
Q4 		– Sell
-50,700
Closed -$837K – 2518
2016
Q3 		$837K Buy
50,700
+900
+2% +$13.3K ﹤0.01% 1440
2016
Q2 		$669K Sell
49,800
-5,800
-10% -$84.6K ﹤0.01% 1369
2016
Q1 		$850K Buy
55,600
+21,300
+62% +$334K ﹤0.01% 1200
2015
Q4 		$681K Buy
34,300
+7,800
+29% +$148K ﹤0.01% 1205
2015
Q3 		$468K Sell
26,500
-7,801
-23% -$159K ﹤0.01% 1328
2015
Q2 		$694K Buy
+34,301
New +$662K 0.01% 1277
2014
Q4 		– Sell
-42,400
Closed -$936K – 2941
2014
Q3 		$936K Sell
42,400
-7,000
-14% -$143K 0.01% 1160
2014
Q2 		$994K Sell
49,400
-32,800
-40% -$556K 0.01% 1196
2014
Q1 		$1.53M Buy
+82,200
New +$1.13M 0.01% 900
2013
Q3 		– Sell
-19,300
Closed -$230K – 2531
2013
Q2 		$230K Buy
+19,300
New +$209K ﹤0.01% 1889

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Two Sigma Advisers's AMRI Position: Q3 2017 in Review

Two Sigma Advisers sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 43,700 shares — an estimated $948K sold.

Two Sigma Advisers first reported a position in AMRI in Q2 2013 and held it in 12 quarters. The position peaked at $1.53M in Q1 2014. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Two Sigma Advisers reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Two Sigma Advisers sold 43,700 Albany Molecular Research Inc shares in Q3 2017, an estimated $948K.
  • Two Sigma Advisers first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 12 quarters.
  • Two Sigma Advisers's Albany Molecular Research Inc position peaked at $1.53M in Q1 2014.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Two Sigma Advisers's 13F filing for Q3 2017, filed 14 Nov 2017.